Stay updated on Ipilimumab Plus Talimogene Laherparepvec Clinical Trial

Sign up to get notified when there's something new on the Ipilimumab Plus Talimogene Laherparepvec Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ipilimumab Plus Talimogene Laherparepvec Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Added Melanoma and related topics (MedlinePlus Genetics) and updated the revision to v3.6.5, replacing the previous v3.6.4.
    Difference
    0.1%
    Check dated 2026-08-11T19:38:03.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The melanoma entry and the related topics header (including MedlinePlus Genetics) were removed from the page's related topics area, reducing disease-specific navigation on this study record.
    Difference
    0.1%
    Check dated 2026-08-04T14:52:53.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    Melanoma is added as a primary topic, and a related topics reference (MedlinePlus Genetics) is included, expanding the page's topic coverage. The revision status is updated from v3.6.3 to v3.6.4.
    Difference
    0.1%
    Check dated 2026-07-28T12:15:31.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Removed the 'Melanoma' condition label from the study details and deleted the MedlinePlus Genetics related topics entry, including the 'related topics' header; this changes how the condition is described on the page and reduces exposure to external related information.
    Difference
    0.1%
    Check dated 2026-07-21T11:42:13.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.3, replacing the previous Revision: v3.6.0. This indicates a small backend or content metadata update without changing study content or user-facing actions.
    Difference
    0.0%
    Check dated 2026-06-30T01:23:02.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    The page now shows a recruitment-status note indicating the study is not enrolling. It also adds new help/navigation items (e.g., 'How to Read a Study Record', 'Common Questions', 'How to Join a Study') and includes minor formatting updates (Intervention/Treatment) along with a revision badge update to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-15T18:04:41.000Z thumbnail image

Stay in the know with updates to Ipilimumab Plus Talimogene Laherparepvec Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ipilimumab Plus Talimogene Laherparepvec Clinical Trial page.